Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating two psycho-physical interventions for people with moderate to severe alcohol use disorder AUD to reduce heavy drinking days and prevent relapse. The study compares Mindfulness Based Relapse Prevention MBRP, a structured program involving mindfulness practice, with an unguided meditative relaxation program. This research addresses the need for effective therapies in AUD, as only a small percentage of patients receive approved drugs, and some patients are resistant to cognitive behavioral therapies. Participants will be randomly assigned to either the MBRP group or a relaxationmeditation control group. MBRP involves seven sessions lasting 60 to 120 minutes each, covering topics such as triggers, relapse prevention, and mindfulness in daily life, including meditation exercises and discussions on at-home practice. The relaxation group attends seven sessions of unguided relaxation with nature sounds, accommodating up to 12 participants per group. Throughout the study, participants will be monitored for changes in heavy drinking days, alcohol consumption, craving frequency and strength, anxiety, depression, quality of life, emotion regulation, impulsivity, coping mechanisms, and cognitive impairment over 3, 6, and 12 months. Researchers will track the number of meditation sessions and assess mental health and behavioral changes. The primary outcome is the reduction in heavy drinking days six months after inclusion, with continued evaluations up to one year.
Actively Recruiting
Healthy Volunteer
Researchers are investigating subjects with germline GATA2 gene mutations to understand factors that predict clonal evolution in these individuals. This study includes both retrospective and prospective groups and aims to characterize the timing of certain clinical events over a 5-year period for each patient. It is an open-label, multi-site, interventional study involving 250 participants. Participants in the prospective group will provide biological samples such as blood and bone marrow at a baseline visit and during standard care over 5 years, without any additional sampling for the study. The retrospective group involves analysis of archived samples and clinical data from deceased or lost-to-follow-up patients previously identified with the mutation. No extra interventions beyond standard care are performed. Throughout the study, participants will be followed for clinical events related to their condition, with data collected from routine care visits and medical records. The primary outcome measures the time from birth to specific clinical events over 5 years. Secondary outcomes include time to other health events and disease-free survival. The study ensures ongoing monitoring without requiring additional procedures beyond standard medical practice.